鋭明技術(002970.SZ):公司在商用車視頻遠程信息處理方案安裝量排名全球第一
格隆匯6月20日丨鋭明技術(002970.SZ)在投資者互動平台表示,車路協同是一個複雜的車聯網大系統,公司主要產品/技術集中在智能感知和決策的車載終端以及大數據引擎的雲平台。根據2024年Berg Insight 5th的報吿,公司在商用車視頻遠程信息處理方案安裝量排名全球第一。公司與小馬智行沒有合作項目。關於無人駕駛,無人駕駛系統涉及面很廣,鋭明的產品主要是集中在給低速無人駕駛作業車提供全套的智能感知、決策硬件和聯網遠程控制平台,當前受限於法規約束和技術成熟度不高,行業整體處於早期探索階段,產品形態多樣,目前暫未形成規模效應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.